EVA MARIA GALVEZ BUERBA
Instituto
- TREATMENT OF FUNGAL INFECTIONS OR DISEASES
- USE OF SSDIMETHYLGLIOTOXIN AS DIAGNOSTIC MARKER OF PHATOLOGIES CAUSED BY GLIOTOXINPRODUCING FUNGI OR THEIR DERIVATIVES
- USE OF SSDIMETHYLGLIOTOXIN AS DIAGNOSTIC MARKER OF PHATOLOGIES CAUSED BY GLIOTOXINPRODUCING FUNGI OR THEIR DERIVATIVES
- USE OF SSDIMETHYLGLIOTOXIN AS DIAGNOSTIC MARKER OF PHATOLOGIES CAUSED BY GLIOTOXINPRODUCING FUNGI OR THEIR DERIVATIVES
- USE OF SSDIMETHYLGLIOTOXIN AS DIAGNOSTIC MARKER OF PHATOLOGIES CAUSED BY GLIOTOXINPRODUCING FUNGI OR THEIR DERIVATIVES
- USE OF SSDIMETHYLGLIOTOXIN AS DIAGNOSTIC MARKER OF PHATOLOGIES CAUSED BY GLIOTOXINPRODUCING FUNGI OR THEIR DERIVATIVES
- USE OF SSDIMETHYLGLIOTOXIN AS DIAGNOSTIC MARKER OF PHATOLOGIES CAUSED BY GLIOTOXINPRODUCING FUNGI OR THEIR DERIVATIVES
- USO DE SSDIMETILGLIOTOXINA COMO MARCADOR DIAGNOSTICO DE PATOLOGIAS CAUSADAS POR HONGOS PRODUCTORES DE GLIOTOXINA O DE SUS DERIVADOS
- TREATMENT OF FUNGAL INFECTIONS OR DISEASES